Compare TEVA & WAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEVA | WAB |
|---|---|---|
| Founded | 1901 | 1869 |
| Country | Israel | United States |
| Employees | 32842 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Railroads |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.7B | 40.8B |
| IPO Year | N/A | 1996 |
| Metric | TEVA | WAB |
|---|---|---|
| Price | $28.55 | $232.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 9 |
| Target Price | $37.38 | ★ $268.67 |
| AVG Volume (30 Days) | ★ 6.3M | 683.1K |
| Earning Date | 04-29-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 0.52% |
| EPS Growth | N/A | ★ 13.08 |
| EPS | N/A | ★ 6.83 |
| Revenue | N/A | ★ $2,391,122,000.00 |
| Revenue This Year | N/A | $11.50 |
| Revenue Next Year | $2.51 | $6.06 |
| P/E Ratio | ★ $28.19 | $34.72 |
| Revenue Growth | N/A | ★ 21.52 |
| 52 Week Low | $12.47 | $151.81 |
| 52 Week High | $37.35 | $266.27 |
| Indicator | TEVA | WAB |
|---|---|---|
| Relative Strength Index (RSI) | 31.56 | 33.42 |
| Support Level | $28.38 | $227.08 |
| Resistance Level | $31.99 | $236.00 |
| Average True Range (ATR) | 1.03 | 5.38 |
| MACD | -0.27 | -2.63 |
| Stochastic Oscillator | 6.81 | 7.06 |
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Westinghouse Air Brake Technologies Corp provides value-added, technology-based products and services for the freight rail and passenger transit industries and the mining, marine, and industrial markets. It provides its products and services through two main business segments: Freight and Transit. The company generates maximum revenue from the Freight segment, which manufactures new and modernized locomotives, provides aftermarket parts and services to existing locomotives, provides components to new and existing freight cars; builds new commuter locomotives; supplies rail control and infrastructure products, including electronics, positive train control equipment, signal design, and engineering services. Geographically, it generates a majority of its revenue from the United States.